omeprazole and Amentia
omeprazole has been researched along with Amentia in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the impact of MHRA DHPCs on prescribing practice in the secondary-care setting, looking specifically at a drug-drug interaction-the concomitant use of clopidogrel and proton pump inhibitors (PPIs) [as omeprazole]-and a drug-disease contraindication-the use of conventional (typical) antipsychotics in dementia." | 3.79 | The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis. ( Coleman, JJ; Dhami, A; Hodson, J; McIlroy, G; Thomas, SK, 2013) |
"Pantoprazole was the most frequently used PPI agent." | 1.91 | Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. ( Ahn, N; Baumeister, SE; Gerlach, R; Günter, A; Güntner, F; Linseisen, J; Meisinger, C; Nolde, M; Rückert-Eheberg, IM; Tauscher, M; Wawro, N, 2023) |
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Weiss, A | 2 |
Gingold-Belfer, R | 2 |
Boltin, D | 1 |
Beloosesky, Y | 1 |
Koren-Morag, N | 1 |
Meyerovitch, J | 1 |
Sharon, E | 1 |
Schmilovitz-Weiss, H | 2 |
Du, J | 1 |
Lai, Y | 1 |
Zhang, L | 1 |
Ahn, N | 1 |
Wawro, N | 1 |
Baumeister, SE | 1 |
Nolde, M | 1 |
Gerlach, R | 1 |
Tauscher, M | 1 |
Günter, A | 1 |
Güntner, F | 1 |
Rückert-Eheberg, IM | 1 |
Meisinger, C | 1 |
Linseisen, J | 1 |
Thomas, SK | 1 |
Hodson, J | 1 |
McIlroy, G | 1 |
Dhami, A | 1 |
Coleman, JJ | 1 |
Other Studies
5 other studies available for omeprazole and Amentia
Article | Year |
---|---|
Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline.
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole; Proton Pump Inhibitors; Retrospective Stu | 2022 |
Chronic omeprazole use in the elderly: Is it related to the risk of dementia and cognitive decline?
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole | 2022 |
Author's Reply: "Chronic omeprazole use in the elderly: Is it related to the risk of dementia and cognitive decline?"
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole | 2022 |
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Topics: Cognitive Dysfunction; Dementia; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors | 2023 |
The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Clopidogrel; Communication; Dementia; | 2013 |